2013 Annual Meeting | Cerebrovascular Disease

Date Sunday 03/17/13

Time 10:00 AM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Cheryl Bushnell, MD, MHS

Topic(s)

Learning Objectives Participants should be familiar with the latest recommendations and controversies regarding the evaluation and management of patients with all stroke types, including acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage; be able to initiate optimal secondary prevention strategies after ischemic stroke, including selection of the optimal antithrombotic agent using the most recently published data and appropriate aggressive risk factor management; be able to manage intracranial and extracranial large artery occlusive disease, selecting the best surgical or endovascular option; be able to recognize differences in risk factors and outcomes based on gender; and utilize tools to improve the quality of stroke care.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive

Event Timeline
10:00 AM - 10:45 AM		Contemporary Management of Acute Ischemic Stroke Pooja Khatri, MD, FAAN
10:45 AM - 10:50 AM		Questions and Answers Pooja Khatri, MD, FAAN
10:50 AM - 11:35 AM		Contemporary Management of Intracranial and Extracranial Large Vessel Disease Edward Feldmann, MD
11:35 AM - 11:40 AM		Questions and Answers Edward Feldmann, MD
11:40 AM - 11:55 AM		Break
11:55 AM - 12:40 PM		The Spectrum of Stroke in Young Adults: Diagnosis and Management Cheryl Bushnell, MD, MHS
12:40 PM - 12:45 PM		Questions and Answers Cheryl Bushnell, MD, MHS
12:45 PM - 01:45 PM		Lunch
01:45 PM - 02:30 PM		Stroke Prevention in Atrial Fibrillation Moira Kapral, MD
02:30 PM - 02:35 PM		Questions and Answers Moira Kapral, MD
02:35 PM - 03:20 PM		Update on Recurrent Stroke Prevention: Guidelines and New Evidence That May Influence Practice Philip B. Gorelick, MD, MPH, FAAN
03:20 PM - 03:30 PM		Questions and Answers Philip B. Gorelick, MD, MPH, FAAN
03:30 PM - 03:45 PM		Break
03:45 PM - 04:30 PM		Contemporary Management of Intracerebral Hemorrhage Mustapha A. Ezzeddine, MD, FAAN
04:30 PM - 04:40 PM		Questions and Answers Mustapha A. Ezzeddine, MD, FAAN
04:40 PM - 05:25 PM		Contemporary Management of Subarachnoid Hemorrhage Vineeta Singh, MD, FAAN
05:25 PM - 05:30 PM		Questions and Answers Vineeta Singh, MD, FAAN
05:30 PM - 06:00 PM		Discussion

Faculty Disclosures
Cheryl Bushnell, MD, MHS	Dr. Bushnell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZZ Biotech. The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from AHRQ. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Pooja Khatri, MD, FAAN	The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Edward Feldmann, MD	No disclosure on file
Moira Kapral, MD	The institution of Moira Kapral, MD has received research support from Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research.
Philip B. Gorelick, MD, MPH, FAAN	Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.
Mustapha A. Ezzeddine, MD, FAAN	The institution of Dr. Ezzeddine has received research support from NIH.
Vineeta Singh, MD, FAAN	Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genae Americas, Inc. .

��ɫ��

��ɫ��